In addition to MECP2 mutations, cyclin-dependent kinase-like 5 (CDKL5) and Netrin G1, two other genes have recently been known in patients with clinical phenotype of Rett syndrome (10-14). This evidence concerns the gene MECP2 and atypical Rett syndrome.